Market Overview:
The global solifenacin succinate drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of urinary incontinence, rising geriatric population, and growing demand for solifenacin succinate drugs. By type, the 5 mg tablet segment is expected to account for a major share of the global solifenacin succinate drug market in 2018. By application, the hospital segment is projected to dominate the global solifenacin succinate drug market during the forecast period. Geographically, North America is estimated to account for a major share of the global solifenacin succinate drug market in 2018.
Product Definition:
Solifenacin Succinate Drug is a type of urinary antispasmodic agent. It helps to relax the muscles around the bladder and urethra, which makes it easier to pass urine. This drug is important because it can help relieve symptoms such as pain, spasms, and difficulty urinating associated with an overactive bladder.
5 mg Tablet:
5 mg tablet, also known as solifenacin succinate, is an anti-inflammatory drug used for the treatment of chronic non-healing skin lesions and warts. It is approved by the Food and Drug Administration (FDA) for the treatment of veruccae caused by fungal infections in patients with HIV infection. The drug was developed as a result of research undertaken to develop drugs that have activity against both prokinetic and antokinetic agents.
10 mg Tablet:
10 mg tablet is used for the treatment of cold and flu symptoms, upper respiratory infections, bronchitis, and tonsillitis. It is also used to reduce the duration and severity of common viral illnesses such as influenza.
Application Insights:
The global solifenacin succinate drug application is segmented into hospital and retail/non-prescription drugs. In 2017, the hospital segment dominated the market with a revenue share of over 90%. This can be attributed to high usage rates for various skin conditions such as acne, eczema and psoriasis in developed countries such as U.S., Canada, U.K., Germany etc. Furthermore, increasing awareness about these products among patients suffering from moderate to severe acne is expected to drive growth during the forecast period.
Regional Analysis:
Europe dominated the global market in 2017 owing to the high prevalence of COPD and presence of a large number of global players. In addition, increasing R&D activities for new drug development is also expected to drive growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period due to rising disposable income, improving healthcare infrastructure and growing awareness about early diagnosis among patients. Moreover, increasing demand for generic drugs from low-income countries will further boost revenue generation in this region.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This will lead to an increase in the number of people suffering from various urinary tract disorders, including overactive bladder (OAB), which will drive the demand for solifenacin succinate drugs.
- Growing awareness about OAB: There is a growing awareness among people about OAB and its treatment options. This is likely to boost the demand for solifenacin succinate drugs in the coming years.
- Availability of generic versions: The availability of low-cost generic versions of solifenacin succinate drugs will help to drive their uptake in developing countries.
- Rising incidence of urinary tract infections: The incidence of urinary tract infections (UTIs) is on the rise globally, due to factors such as changing lifestyles and increasing antibiotic resistance rates among bacteria strains involved in UTIs pathogenesis .This will lead to an increase in demand for solifenacin succinate drugs as they are effective against UTIs caused by Escherichia coli and other bacteria strains resistant to antibiotics . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Solifenacin Succinate Drug Market Research Report
By Type
5 mg Tablet, 10 mg Tablet
By Application
Hospital, Drug store
By Companies
Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Cipla, Jiangxi Boya Seehot Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Solifenacin Succinate Drug Market Report Segments:
The global Solifenacin Succinate Drug market is segmented on the basis of:
Types
5 mg Tablet, 10 mg Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astellas Pharma
- Teva
- Ajanta Pharma
- Aurobindo Pharma
- Glenmark Pharmaceuticals
- Qilu Pharmaceutical
- Cipla
- Jiangxi Boya Seehot Pharmaceutical
Highlights of The Solifenacin Succinate Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5 mg Tablet
- 10 mg Tablet
- By Application:
- Hospital
- Drug store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Solifenacin Succinate Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Solifenacin succinate is a medication used to treat pain and inflammation. It is available in tablet form. Solifenacin succinate works by blocking nerve cells from sending signals that cause pain.
Some of the major companies in the solifenacin succinate drug market are Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Cipla, Jiangxi Boya Seehot Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Solifenacin Succinate Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Solifenacin Succinate Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Solifenacin Succinate Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Solifenacin Succinate Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Solifenacin Succinate Drug Market Size & Forecast, 2020-2028
4.5.1 Solifenacin Succinate Drug Market Size and Y-o-Y Growth
4.5.2 Solifenacin Succinate Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 5 mg Tablet
5.2.2 10 mg Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Solifenacin Succinate Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Solifenacin Succinate Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 5 mg Tablet
9.6.2 10 mg Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 5 mg Tablet
10.6.2 10 mg Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 5 mg Tablet
11.6.2 10 mg Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 5 mg Tablet
12.6.2 10 mg Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 5 mg Tablet
13.6.2 10 mg Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Solifenacin Succinate Drug Market: Competitive Dashboard
14.2 Global Solifenacin Succinate Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Astellas Pharma
14.3.2 Teva
14.3.3 Ajanta Pharma
14.3.4 Aurobindo Pharma
14.3.5 Glenmark Pharmaceuticals
14.3.6 Qilu Pharmaceutical
14.3.7 Cipla
14.3.8 Jiangxi Boya Seehot Pharmaceutical
